DCT

2:22-cv-02964

Aragon Pharmaceuticals Inc v. Zydus Worldwide DMCC

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

Filed

05/20/22

Cause Of ActionPatent Infringement

SectorBiotech

StatusOpen

Patent Owner

Operating Company

PACER

Nature of Suit835 ANDA

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Period	PO Win Rate
Stanley R. Chesler	07/20/23 - now	50%
Evelyn Padin	07/20/23 - 07/20/23	50%

MagistrateLeda D. Wettre

Plaintiff

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Aragon Pharmaceuticals Inc	L5 A
Janssen Pharmaceuticals Inc	L5 A
Sloan-Kettering Institute for Cancer Research Inc	L1 D

No Parties

Attorney

Name	Ratings
Akin Gump Strauss Hauer & Feld LLP	L5 A
Patrick J. Coyne	L5 A
Neal S. Cohen	L5 A
Robert D. Bajefsky	L5 A
Scott J. Popma	L5 A
Jennifer S. Swan	L5 A
Aaron M. Raphael	L5 A
Robinson MillerLocal	L5 A
Peter Kinsella	L5 A
Scott E. Holwick	L5 A

No Attorneys

Defendant

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Zydus Worldwide DMCC	L4 E
Zydus Pharmaceuticals USA Inc	L4 E
Zydus Lifesciences Ltd	L4 E

No Parties

Attorney

No Attorneys